Amgen launches Humira biosimilar Amjevita for rheumatoid arthritis

The price of Amgen's rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.

Related Keywords

Mackay Jimeson ,Abbvie Humira ,Cardinal Healthsurvey ,Eli Lilly ,Amgen ,Pfizer ,Boehringer Ingelheim ,United States ,Patient Access ,Affordability Project ,